Combined Effect of Genetic Polymorphisms of AURKA and Environmental Factors on Oral Cancer Development in Taiwan
Overview
Affiliations
Background: Oral squamous cell carcinoma (OSCC) is the sixth and fourth most common cause of cancer death in men worldwide and in Taiwan, respectively. AURKA, which encodes a centrosome-related serine/threonine kinase, is frequently amplified and overexpressed in many human cancers, particularly advanced OSCC. We conducted a hospital-based case-control study to estimate AURKA single-nucleotide polymorphisms (SNPs) and environmental risk factors to determine OSCC susceptibility and clinicopathological characteristics.
Methodology/principal Findings: We enrolled a total of 876 OSCC patients and 1200 controls. Four SNPs of AURKA, namely rs1047972, rs2273535, rs2064863, and rs6024836, were analyzed using real-time polymerase chain reaction (PCR). Among the 1420 smokers, the AURKA polymorphism carriers with the betel nut chewing habit had a higher risk of oral cancer than AURKA wild-type (WT) carriers without the betel nut chewing habit. Patients with the AURKA rs2064863 gene had a 1.365-fold higher risk of stage III or IV OSCC (95% confidence interval [CI] 1.029-1.811) than those with the rs2064863 WT gene. Furthermore, carriers of the AURKA rs1047972/rs2273535/rs2064863 C-A-T haplotype had a 1.736-fold (95% CI 1.110-2.715) higher risk of OSCC than controls (C-T-T, the most common haplotype). Among patients with the betel quid chewing habit, carriers of other haplotypes (C-T-T, C-A-G, T-A-T, T-A-G, T-T-T, and C-T-G) had a 12.857-fold (95% CI 10.731-15.404) increased risk, and carriers of the C-A-T haplotype had the highest risk (AOR: 31.120; 95% CI 13.864-69.850) of OSCC, compared with those without the betel quid chewing who harbored other haplotypes.
Conclusions: In conclusion, betel nut chewing combined with the AURKA C-A-T haplotypes lead to a high risk of OSCC. These findings reveal a novel genetic-environmental predisposition for oral tumorigenesis.
Hsu C, Hong S, Lo Y, Ho H, Lin C, Chuang Y Int J Mol Sci. 2024; 25(19).
PMID: 39408657 PMC: 11476886. DOI: 10.3390/ijms251910328.
Garajei A, Allameh A, Azadi M, Emami A, Atashbasteh M, Mostafavi M Diagnostics (Basel). 2023; 13(7).
PMID: 37046462 PMC: 10093007. DOI: 10.3390/diagnostics13071244.
Taherkhani A, Dehto S, Jamshidi S, Shojaei S Genomics Inform. 2022; 20(3):e27.
PMID: 36239104 PMC: 9576470. DOI: 10.5808/gi.22038.
Zhao T, Hu H, Chen X, Liu Y, Wang H, Li X Am J Transl Res. 2022; 14(7):4617-4627.
PMID: 35958512 PMC: 9360857.
Guo J, Li W, Cheng L, Gao X Int J Gen Med. 2022; 15:3933-3941.
PMID: 35431572 PMC: 9012340. DOI: 10.2147/IJGM.S353708.